Company / PP&E per Share
Beam Therapeutics Inc. PP&E per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$1.03
FY2025
5-year range
$1.03 / $1.62
FY2021-FY2025
Trend
-22.9%
vs FY2024
Sector context
#46 of 191
Health Care
What the data says
Beam Therapeutics Inc.'s pp&e per share of $1.03 is higher than 76% of companies in the Health Care sector (FY2025). PP&E per Share has declined for 3 consecutive years, from $1.62 in FY2022 to $1.03 in FY2025.
Based on SEC 10-K filings.
1.03 in FY2025 with a 5-year CAGR of -27.9%. Top quartile in the Health Care sector.
Declined from $1.53 to $1.03 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -14.1%
- 5-Year CAGR
- -27.9%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 191This company $1.03 Sector average $22.34
▼
-95.4% below sector average
Key checks
Key Insights
- Beam Therapeutics Inc.'s pp&e per share has declined for 3 consecutive years.
- In FY2025, pp&e per share decreased 22.9% year-over-year.
- Ranks #46 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.03 | -22.9% |
| FY2024 | $1.33 | -13.0% |
| FY2023 | $1.53 | -5.6% |
| FY2022 | $1.62 | +31.7% |
| FY2021 | $1.23 | -76.6% |
| FY2020 | $5.26 | +40.2% |
| FY2019 | $3.75 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026